Your browser doesn't support javascript.
loading
Prediction model for cardiac allograft vasculopathy: Comparison of three multivariable methods.
Kransdorf, Evan P; Loghmanpour, Natasha A; Kanwar, Manreet K; Temkit, M'hamed H; Stehlik, Josef.
Afiliação
  • Kransdorf EP; Cedars-Sinai Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Loghmanpour NA; Department of Biomedical Engineering, Carnegie Mellon University, Pittsburgh, PA, USA.
  • Kanwar MK; Cardiovascular Institute, Allegheny General Hospital, Pittsburgh, PA, USA.
  • Temkit MH; Division of Health Sciences Research, Mayo Clinic Arizona, Scottsdale, AZ, USA.
  • Stehlik J; Division of Cardiovascular Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA.
Clin Transplant ; 31(4)2017 04.
Article em En | MEDLINE | ID: mdl-28181298
ABSTRACT

BACKGROUND:

Cardiac allograft vasculopathy (CAV) remains an important cause of graft failure after heart transplantation (HT). Although many risk factors for CAV have been identified, there are no clinical prediction models that enable clinicians to determine each recipient's risk of CAV.

METHODS:

We studied a cohort of 14 328 heart transplant recipients whose data were reported to the International Society for Heart and Lung Transplantation Registry between 2000 and 2010. The cohort was divided into training (75%) and test (25%) sets. Multivariable modeling was performed in the test set using variables available at the time of heart transplant using three

methods:

(i) stepwise Cox proportional hazard, (ii) regularized Cox proportional hazard, and (iii) Bayesian network.

RESULTS:

Cardiac allograft vasculopathy developed in 4259 recipients (29.7%) at a median time of 3.0 years after HT. The regularized Cox proportional hazard model yielded the optimal performance and was also the most parsimonious. We deployed this model as an Internet-based risk calculator application.

CONCLUSIONS:

We have developed a clinical prediction model for assessing a recipient's risk of CAV using variables available at the time of HT. Application of this model may allow clinicians to determine which recipients will benefit from interventions to reduce the risk of development and progression of CAV.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Complicações Pós-Operatórias / Modelos de Riscos Proporcionais / Transplante de Coração / Rejeição de Enxerto / Cardiopatias Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Transplant Assunto da revista: TRANSPLANTE Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Complicações Pós-Operatórias / Modelos de Riscos Proporcionais / Transplante de Coração / Rejeição de Enxerto / Cardiopatias Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Transplant Assunto da revista: TRANSPLANTE Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos